Aehr Test Systems, Inc.
55.31USD
-0.3400 (-0.61%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on AEHR.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 50.8M | 65.0M | 66.2M | 59.0M | 50.0M | — |
| Q1 | 5.6M | 10.7M | 20.6M | 13.1M | 11.0M | 27.5M |
| Q2 | 9.6M | 14.8M | 21.4M | 13.5M | 9.9M | 38.9M |
| Q3 | 15.3M | 17.2M | 7.6M | 18.3M | 10.3M | — |
| Q4 | 20.3M | 22.3M* | 16.6M* | 14.1M* | 18.8M* | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | .340 | .500 | 1.12 | -.130 | -.230 | — |
| Q1 | .030 | .020 | .160 | .020 | -.070 | .127 |
| Q2 | .030 | .000 | .200 | -.030 | -.110 | .230 |
| Q3 | .080 | .140 | -.050 | -.020 | -.100 | — |
| Q4 | .200 |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| .209* |
| .806* |
| -.098* |
| .045* |
| — |
Debt level and coverage